Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries's Climate Target Data Preview
As of 2023, Teva Pharmaceutical Industries has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Teva Pharmaceutical Industries ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2025 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Teva Pharmaceutical Industries's Greenhouse Gas Emissions Pathways
As of 2023, Teva Pharmaceutical Industries has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Teva Pharmaceutical Industries have a target to reduce the emissions from its operations?
As of 2023, Teva Pharmaceutical Industries has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Teva Pharmaceutical Industries's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 647,500 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.
As of 2023, Teva Pharmaceutical Industries is ahead of schedule on its operational emissions reduction target, having achieved 59.24% of the planned reduction.
Teva Pharmaceutical Industries's Operational (Scope 1+2) Emissions Pathway
Does Teva Pharmaceutical Industries have a target to reduce the emissions from its value chain?
As of 2023, Teva Pharmaceutical Industries has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
Teva Pharmaceutical Industries's most ambitious value chain target is to reduce these emissions by 25% by 2030, compared to a baseline of 6,915,858 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.
As of 2023, Teva Pharmaceutical Industries is ahead of schedule on its value chain emissions reduction target, having achieved 49.12% of the planned reduction.